Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06306287 · ClinicalTrials.gov registry record · NA

Adolescent Screening and Personalized Intervention Resource for Enhancement of Behavioral Health and Substance Use

A NA study of Substance Use and Mental Health Issue, sponsored by Oregon Research Institute.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06306287 is a NA study of Substance Use and Mental Health Issue that is actively recruiting participants, run by Oregon Research Institute. The registered enrollment target is 120 participants, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06306287, a NA study of Substance Use and Mental Health Issue, is actively recruiting participants, sponsored by Oregon Research Institute.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Only a small fraction of youth who are beginning to experience behavioral health problems and use alcohol or illicit drugs receive needed treatment services due to the lack of accessible, effective early intervention resources. The goal of this clinical trial is to compare a personalized brief web-based early intervention, eHealth Personalized Approach for Change Efficacy (ePACE), in which youth are offered choices regarding intervention content and desired level of engagement, to a "fixed", non-tailored brief intervention, eHealth Fixed Approach for Change Efficacy (eFACE) for adolescents with mild/moderate substance use and common co-occurring problems. Both ePACE and eFACE include a multi-problem screener that guides youths through a set of key integrated behavior change and counseling modules providing a cohesive focus on these four problem domains: drug abuse, interpersonal relations, negative emotions and stress. The main questions the trial aims to answer are: * Are substance use and co-occurring problem outcomes for ePACE and eFACE are superior to those for a waitlist comparison group (WC) * Are outcomes for ePACE are superior to those for eFACE * Are the direct effects of ePACE and eFACE (i.e., the improvements in substance use and co-occurring problem outcomes) associated with improvements in areas of functioning and new skills that are hypothesized to produce change -- that is, are the improvements shown in the ePACE and eFACE groups due to the mechanisms by which change is hypothesized to occur Participants in ePACE and eFACE will complete a baseline assessment prior to engaging in the intervention to which they are assigned and will complete post-intervention assessments 3 months and 6 months later. Participants in the WC group will complete three assessments: at baseline, 3-months, and 6-months.

Interventions

  • BEHAVIORAL ePACE Personalized Intervention
  • BEHAVIORAL eFACE Fixed Intervention

Study Locations (1)

New Mexico

  • Oregon Research Institute - Albuquerque

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-02-15
Est. Completion 2025-04-30
Phase NA

Sponsor

Oregon Research Institute

62 total trials

What the Registry Record Tells You About NCT06306287

The ClinicalTrials.gov registry entry for NCT06306287 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (90% lower). The listed sponsor is Oregon Research Institute, which has 62 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which ePACE Personalized Intervention is the first listed.

NCT06306287 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.

Frequently Asked Questions

What is clinical trial NCT06306287 about?

NCT06306287 is a clinical study titled "Adolescent Screening and Personalized Intervention Resource for Enhancement of Behavioral Health and Substance Use". Only a small fraction of youth who are beginning to experience behavioral health problems and use alcohol or illicit drugs receive needed treatment services due to the lack of accessible, effective early intervention resources. The goal of this clinical trial is to compare a personalized brief web-b...

What is the current status of trial NCT06306287?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-02-15. Estimated completion is 2025-04-30.

What conditions does trial NCT06306287 study?

This clinical trial studies the following conditions: Substance Use, Mental Health Issue.

What interventions are being tested in trial NCT06306287?

The interventions under investigation include: ePACE Personalized Intervention (BEHAVIORAL), eFACE Fixed Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06306287?

This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06306287 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.